LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 72.27 | 770.25 | 1634 | 10730 | 0.1523 | 0.2188 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 74.50 | 770.25 | 1764 | 10991 | 0.1605 | 0.2412 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 74.50 | 770.25 | 1758 | 10991 | 0.1599 | 0.2401 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.75 | 770.25 | 1855 | 11262 | 0.1647 | 0.2550 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.75 | 770.25 | 1991 | 11262 | 0.1768 | 0.2781 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.98 | 770.25 | 1844 | 11518 | 0.1601 | 0.2507 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.98 | 770.25 | 2049 | 11518 | 0.1779 | 0.2849 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 81.20 | 770.25 | 1845 | 11766 | 0.1568 | 0.2487 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 81.20 | 770.25 | 2012 | 11766 | 0.1710 | 0.2765 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 83.42 | 770.25 | 2047 | 12031 | 0.1701 | 0.2795 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 83.42 | 770.25 | 2270 | 12031 | 0.1887 | 0.3133 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 85.64 | 770.25 | 2028 | 12287 | 0.1651 | 0.2742 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 85.64 | 770.25 | 2101 | 12287 | 0.1710 | 0.2855 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 87.86 | 770.25 | 2255 | 12543 | 0.1798 | 0.3058 | MN20160304_L02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 87.86 | 770.25 | 2521 | 12543 | 0.2010 | 0.3425 | MN20160304_L02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 3.21 | 770.25 | 1018 | 904 | 1.1253 | 2.3271 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 3.21 | 770.25 | 962 | 904 | 1.0634 | 1.6070 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 5.44 | 770.25 | 1106 | 1012 | 1.0921 | 1.4998 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 5.44 | 770.25 | 1044 | 1012 | 1.0309 | 1.1600 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 7.66 | 770.25 | 1150 | 1090 | 1.0550 | 1.2258 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 7.66 | 770.25 | 1068 | 1090 | 0.9798 | 0.9202 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 10.06 | 770.25 | 1200 | 1218 | 0.9848 | 0.9543 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 10.06 | 770.25 | 1058 | 1218 | 0.8683 | 0.6156 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 12.28 | 770.25 | 1251 | 1358 | 0.9211 | 0.8089 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 12.28 | 770.25 | 1162 | 1358 | 0.8556 | 0.6529 | MN20160304_L02 | M11 |